The History of ISAP William A. Craig Symposium Madison, 2008 Otto Cars Uppsala University Sweden.

Slides:

Advertisements

Similar presentations

The Fight Against Infectious Disease

Advertisements

Controlling Antibiotic Resistance in an Aquatic Environment 1 st Year PhD Student - Iona Paterson Primary Supervisor - Dr Andrew Hoyle Secondary Supervisor.

Penicillin, Antibiotics and Testing new drugs

Gena H. Davies Trinity Western University.  Research is “professionalized.” Formal research outlets include: ◦ Journals ◦ Books ◦ Conferences  National.

Evolution in Action. “A turn for the Worse” pg. 59 Scenario.

Animal Model PK/PD: A Tool for Drug Development

Anti-bacteria Medicine. Anti-bacteria medicine Anti-bacteria medicine Antibiotics: The substance derived from fungi and bacteria which can selectively.

Eccmid 2003 Aminoglycosiden bij neonaten Canisius-Wilhelmina Hospital Nijmegen, The Netherlands Johan W Mouton Relationship between bacterial killing,

Augmentin® ES Clinical Microbiology Review

Plasmids Chromosome Plasmid Plasmid + Transposon Plasmid + integron Plasmid+transposon +intergron Chromosome Chromosome + transposon Chromosome + transposon.

From Mystery to Medicine A Multimedia Presentation By: Christina Cuevas California State University Northridge.

Antibiotics & Bacterial Resistance. Antibiotics Are natural substances that stops or destroys microorganisms by attacking metabolic pathways in the bacteria.

Overview of Use of PK-PD in Streamlining Drug Development William A. Craig Professor of Medicine University of Wisconsin.

Chapter 10: Restricting antibiotic use and optimizing dosing.

Pharmacodynamics of Antibiotics

OTC day 2 – materials (pencil, paper, reading label paper, elmo, dry erase) 1.Part I – Reading a label (review from PP presentation) 2.Project the Hand.

Office of Clinical Pharmacology and Biopharmaceutics IDSA/ISAP/FDA Workshop 4/16/04 1 Improvement in Dose Selection: FDA Perspective IDSA/ISAP/FDA Workshop.

25 MB of information … CONTENT OF THE CD-rom Learning appropriate use of antibiotics (PK/PD and guidelines): a CD-rom course for healthcare professionals.

PK/PD of Antibiotics in relation to resistance Otto Cars MD Department of Medical Sciences Infectious diseases Uppsala University Sweden.

Key Individual in Disease and Infection : Paul Ehrlich Key dates: Key discovery Nobel Prize in Medicine, Who? German physician and.

Copyright © 2006 Pearson Education, Inc., publishing as Benjamin Cummings PowerPoint ® Lecture Slide Presentation prepared by Christine L. Case M I C R.

BY: ERICA STIRLING Antibiotics. Instructions Complete the slides using information found online and in the green text book. Add images to all the slides.

Pharmacodynamics of Antimicrobials in Animal Models William A. Craig, M.D. University of Wisconsin-Madison.

Alexander Fleming By: Layal Al-Meslemani. What did he discover? Alexander Fleming’s well known and best/famous discoveries were: 1.The enzyme lysozyme.

1 Antimicrobial Drugs. 2 Antimicrobal Chemotherapy Terms.

PK/PD - ICC - Manila, June 5th, The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place ? Paul.

Pharmacokinetics of Antimicrobials in Animals: Lessons Learned William A. Craig, M.D. University of Wisconsin-Madison.

Bell Ringer “examples”  COMPOUND MICROSCOPE Zacharias Janssen was a Dutch lens-maker who invented the first compound microscope in 1595 (a compound microscope.

Multiple dosing: intravenous bolus administration

Ten Years After: Where is ISAP?

Prof. Hartmut Derendorf University of Florida The Role of Pharmacological Predictors in Drug Development.

Pharmacodynamics of Antifungals

The Rational Use of Antibiotics

Pharmacodynamics of Antimicrobials in Animal Models William A. Craig, M.D. University of Wisconsin-Madison.

Fight the Resistance By: Aaron Browder. History of Antibiotics Louis Pasteur was one of the first recognized physicians who observed that bacteria could.

Regulatory Aspects of PK/PD – (modelling) Karolina Törneke Senior expert, member of the CVMP.

Pharmacodynamic Indices Canisius-Wilhelmina Hospital Nijmegen, The Netherlands Johan W Mouton.

3.4 Solving equations Simultaneous equations. Snakes on planes or How to describe the geometric relationship between planes.

Modified release products. Considerations in the evaluation of modified release products Requirements for preparing extended release products. The bioavailability.

European Patients’ Academy on Therapeutic Innovation The key principles of pharmacology.

Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern Qualitative Antimicrobial.

JWM Grindelwald Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands Johan W. Mouton Pharmacodynamic Indices.

Improvement in Dose Selection Through Clinical PK/PD in Antimicrobial Drug Development: Perspective of an Industry PK/PD Scientist Gregory A. Winchell,

Pharmacodynamics of Antimicrobials William A. Craig, M.D. University of Wisconsin-Madison.

Unit 2 Reading (1) Unit 2 Reading (1) Two life-saving medicines.

antibiotic sensitivity test, a laboratory method for determining the susceptibility of organisms to therapy with antibiotics. After the infecting organism.

Antibiotics are a group of chemicals which destroy bacteria They can kill bacteria or stop their growth The agar plate below shows a clear area around.

Sayed Ali Mus POST GRADUATES-BATCH 6 FACULTY OF MEDICAL LABORATORY SCIENCES PARASITOLOGY DEPARTMENT ALNEELIN UNIVERSITY March 2015 Symposium on: Advances.

"Jason, when did your passion for photography? And why are they gone out of travel photos and became the military reporter? My interest in photography.

Daniel Brandes.  Fleming was a Scottish pharmacologist and biologist who lived from 1881 to  Fleming is best known for his discovery of Penicillin,

Leaders in Science Session 9 Workshop dry run...

The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place ? Paul M. Tulkens Cellular and Molecular.

Antimicrobial Resistance (AMR)

Advisor: Prof. Sabounchi

Biopharmaceutics of modified release drug products

Chapter 1 Introduction to Biopharmaceutics & Pharmacokinetics

Antibiotics and Antibiotic Resistance

Using drugs to treat diseases

Oral session: PK/PD-based optimized broad-spectrum beta-lactam therapy (Sunday 10 April, 11:30) Achieving pharmacokinetic/pharmacodynamic (PK/PD) targets.

PK/PD: from theory to applications in the real world...

Treating Disease Learning Objectives: Describe how antibiotics work.

Dr. Shawn R. Lockhart, PhD D(ABMM)

Simone M. Shurland, Ph.D., Division of Anti-Infective Products

Starter: Can you answer these 4 questions based on last lesson’s work?

P1257 Pharmacodynamics of Amikacin Inhale studied in an in vitro pharmacokinetic model of infection KE Bowker, AR Noel, SG Tomaselli, MLG Attwood, AP.

Pharmacodynamic indices in targeting therapy of critical infections

Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations D. Andes, W.A. Craig Clinical Microbiology.

Pharmaceutical care plans Ola Ali Nassr

Principles of Antimicrobial Therapy

Presentation transcript:

The History of ISAP William A. Craig Symposium Madison, 2008 Otto Cars Uppsala University Sweden

What has Iceland to do with the birth of ISAP ?

What has Guiseppe Verdi to do with the birth of ISAP?

What has this man to do with the birth of ISAP ?

It all began in 1986 after a symposium in Reykjavik, Iceland

It all began in 1986 after a symposium in Reykjavik, Iceland after which we visited

The Icelandic Opera and saw a performance of …

Verdi…… Verdi…

And after that we went to Hotel Saga to have a few soft drinks and discuss to start an internatonal collaboration on dosing of antibiotics

Through the inspiration of the performance, we decided that the acronym of the group should be that of a Verdi opera We tried: FALSTAFF: Federaton for Antibiotics and Like Substances To Achieve Further Facts OTELLO: Organization to Terminate Every Little Living Organism AIDA:Association for Improvement of Dosing of Antibioics

The Association for Improvement of Dosing of Antibiotics

1990 Stockholm The first International Symposium on the Pharmadodynamics of Antibiotics

AIDA becomes ISAP

Berlin 1991

Madison 1991

Integrated symposia Satellite symposia Educational workshops Conferences

1996

Workshops - History In 2000, the first ISAP educational workshop was held in 2000 during ECCMID as a separate event. There were entryfees to cover the cost. These were the times of slides – no ppt. Handouts we provided and prepared : a suitcase was brought to the conferences. In the same year the first ISAP educational workshop was held at ICAAC Toronto A one day workshop with 5 speakers. Since then (2000), workshops have been held a every ECCMID and ICAAC. It is now integrated in ECCMID. The ICAAC workshop has now two afternoon sessions and includes more than 10 speakers.

Regulation Standardization

Points to consider on pharmacokinetics and pharmacodynamics inthe development of antibacterial medicinal products (CPMP/EWP/2655/99) There is a mounting body of evidence to support the use of PK/PD relationship for individual antibacterial agents oin identifying those doses and dose intervals that are most likely to be efficacious and least likely to result in adverse effects and/or the selection of resistant organisms. ISAP-EMEA meeting Wiks Castes sweden

It is time above MIC………

“It is not difficult to make microbes resistant to penicillin … …. The time may come when penicillin can be bought by anyone in the shops. Then there is the danger that the ignorant man may easily underdose himself and by exposing his microbes to non-lethal quantities of the drug make them resistant.” Alexander Fleming's Nobel Lecture, 1945

Optimal antibiotic dosage EfficacyToxicityResistance

Take your time! This ferry is not AUC driven